American Origin Unverified
This profile is unclaimed and has not been independently reviewed.
Claim & get verified
PURPLE BIOTECH LTD.
$2.8MMarket cap
10Employees
PPBTNASDAQ
2015IPO
About PURPLE BIOTECH LTD.
Purple Biotech Ltd is a clinical-stage biotechnology company focused on the development and commercialization of pharmaceuticals. It currently have a preclinical tri-specific antibodies platform, CAPTN-3, with its therapeutic candidates, IM1240 and IM1305, and two other oncology therapeutic candidates that are in the clinical trial phase, CM24 and NT219, neither of which has been approved for marketing and are not being sold, marketed, or commercialized.
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Reported figures
Financial summary
- Market cap
- $2.8M
- Market cap
- $2.8M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Nov 20, 2015
Market data by Polygon.io · prices are 15-minute delayed
No reviews yet. Be the first to review PURPLE BIOTECH LTD..
Write a review
Explore
Browse all →
